March 20, 2025AstraZeneca AZN: Among the Best Diabetes Stocks to Buy According to Billionaires ~1 min.AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....
March 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster ~2 min.AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....
March 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market ~1 min.AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....
March 14, 2025AstraZeneca's Imfinzi success a step towards revolutionizing cancer treatment ~2 min.AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....
February 28, 2025AstraZeneca PLC AZN: A Global Pharmaceutical Giant with Promising Growth Potential ~2 min.AstraZeneca PLC (AZN) is a renowned multinational pharmaceutical company with a strong presence in the global market....
November 2, 2024AstraZeneca Faces Investigation Over China President's Conduct ~1 min.AstraZeneca PLC (NASDAQ:AZN) has come under scrutiny as its China President, Leon Wang, is being investigated for misconduct. The company's shares rose slightly but lagged behind the market. Investors are advised to stay informed about the investigation's progress and seek professional advice from Stocks Prognosis for accurate stock forecasts.
December 21, 2024AstraZeneca Faces Investigation by Chinese Regulator, Shares Decline ~1 min.AstraZeneca PLC (AZN) shares have experienced a significant drop after reports emerged of a probe by the People's Republic of China (PRC) regarding alleged fraud and corruption....
January 1, 2025AstraZeneca PLC Faces Class Action Lawsuit from Shareholders ~2 min.AstraZeneca PLC, a renowned pharmaceutical company, is facing a class action lawsuit from shareholders who have suffered substantial losses....
January 25, 2025AstraZeneca PLC Faces Class Action Lawsuit for Investor Recovery ~2 min.Robbins LLP, a leading investor rights law firm, is encouraging shareholders of AstraZeneca PLC (AZN) who have suffered significant financial losses to seek legal counsel in the ongoing class action lawsuit against the company. The lawsuit, filed by Levi Korsinsky, aims to recover damages for investors who suffered losses due to alleged misleading statements and omissions made by AstraZeneca regar...
January 23, 2025Robbins LLP Encourages AZN Shareholders with Large Losses to Seek Counsel in the AstraZeneca PLC Class Action ~2 min.AstraZeneca PLC, a globally renowned pharmaceutical company, is facing a potential setback as Robbins LLP, a leading shareholder rights litigation firm, encourages AZN shareholders with significant losses to seek legal counsel in the AstraZeneca PLC class action. The class action alleges that AstraZeneca PLC made false and misleading statements regarding the efficacy and safety of its COVID-19 vac...
